BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10980764)

  • 1. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.
    Holbrook JT; Davis MD; Hubbard LD; Martin BK; Holland GN; Jabs DA; Gilpin AK; Meinert C; Reshef DS
    Arch Ophthalmol; 2000 Sep; 118(9):1196-204. PubMed ID: 10980764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cytomegalovirus retinitis. Clinical evaluation vs centralized grading of fundus photographs. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jul; 114(7):791-805. PubMed ID: 8660161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis.
    Jabs DA; Martin BK; Forman MS; Hubbard L; Dunn JP; Kempen JH; Davis JL; Weinberg DV;
    Am J Ophthalmol; 2003 Jan; 135(1):26-34. PubMed ID: 12504693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Am J Ophthalmol; 1997 Aug; 124(2):141-57. PubMed ID: 9262538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
    Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
    Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
    Ophthalmology; 2004 Dec; 111(12):2224-31. PubMed ID: 15582078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical vs photographic assessment of treatment of cytomegalovirus retinitis. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial Report 8. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jul; 114(7):848-55. PubMed ID: 8660169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
    Lalezari JP; Stagg RJ; Kuppermann BD; Holland GN; Kramer F; Ives DV; Youle M; Robinson MR; Drew WL; Jaffe HS
    Ann Intern Med; 1997 Feb; 126(4):257-63. PubMed ID: 9036797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A foveal-sparing pattern of cytomegalovirus retinitis in the acquired immunodeficiency syndrome.
    Luckie AP; Ai E
    Aust N Z J Ophthalmol; 1996 Feb; 24(1):53-9. PubMed ID: 8743006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.
    J Infect Dis; 1997 Jul; 176(1):50-8. PubMed ID: 9207349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Ann Intern Med; 1997 Feb; 126(4):264-74. PubMed ID: 9036798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.
    Patel SS; Rutzen AR; Marx JL; Thach AB; Chong LP; Rao NA
    Ophthalmology; 1996 Sep; 103(9):1476-82. PubMed ID: 8841309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Jabs DA; Dunn JP; Enger C; Forman M; Bressler N; Charache P
    Arch Ophthalmol; 1996 Jul; 114(7):809-14. PubMed ID: 8660163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
    Dunn JP; MacCumber MW; Forman MS; Charache P; Apuzzo L; Jabs DA
    Am J Ophthalmol; 1995 May; 119(5):587-96. PubMed ID: 7733184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Tufail A; Moe AA; Miller MJ; Wagar EA; Bruckner DA; Holland GN
    Ophthalmology; 1999 Jan; 106(1):133-41. PubMed ID: 9917794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
    Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
    Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.